Advanced Drug Delivery Systems Market size was valued at USD 52.28 billion in 2021 and is projected to reach up to USD 145.0 billion in 2028, exhibiting a CAGR of 16.1% in the forecast period.
The phrase “advanced drug delivery” describes the procedures, formulations, and administration routes utilised to deliver medications for a range of medical applications or therapeutic goals. A more regulated method of getting the drug molecule to the intended spot is called advanced drug delivery. A drug delivery system that uses cutting-edge technology and unique drug delivery tactics is referred to as an advance drug delivery system. They are made to deliver medications to tissue or cells in a controlled or modulated manner, leading to safe and efficient therapy.
Advanced drug delivery systems have several advantages over conventional ones, including the capacity to deliver a drug more precisely to a particular site, simpler, more accurate, fewer frequent dosing, decreased variability in systemic drug concentrations, absorption that is more consistent with the site and mechanism of action, and decreases in toxic metabolites. The advanced drug delivery system includes liposomes, niosomes, dendrimers, polymeric or lipid-based carriers, nanoparticles, nanospheres, nanocapsules, nanoemulsions, and other drug delivery systems as well as oral, parenteral, pulmonary, transmucosal, and transdermal drug delivery systems.
Fill Out Details to Receive FREE Sample Report Copy Here:
https://analyticsmarketresearch.com/sample-request/advanced-drug-delivery-systems-market/122/
Key Companies Insights
Key players are focusing on their technological partnerships, collaborations, and merger & acquisitions strategies to gain a competitive edge and expand their product portfolio & business footprint. The ongoing Covid-19 pandemic hampered the systems across the globe and drove market players to innovate products for several opportunities.
Some of the key players operating in the global advanced drug delivery systems market include:
- Baxter
- Boston Scientific Corporation
- AbbVie Inc.
- Becton, Dickinson and Company
- Kindeva Drug Delivery L.P
- Bausch Health Companies Inc.
- Novo Nordisk A/S
- Ocular Therapeutix, Inc.
- 3M
- Raphas Co., Ltd.
- GALDERMA
- NanoPass
- Altaris
- MicropointTechnologies
- Takeda Pharmaceutical Company Limited
- Other players
Some of the Recent Developments:
- In March 2022, Corium, Inc. received United States Food and Drug Administration (FDA) approval for Corium’s ADLARITY (donepezil transdermal system) for the treatment of patients with mild, moderate, or severe dementia of the Alzheimer’s type.
- In March 2022, the United States Food and Drug Administration approved the first generic of Symbicort Inhalation Aerosol for the treatment of two common pulmonary health conditions: asthma in patients of six years of age and older, and chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
- In February 2019, Sandoz, a Novartis division, received European Commission authorization in Spain for its adalimumab biosimilar, HYRIMOZ, for subcutaneous injection in a syringe or a prefilled pen.
Segments
By Type
- Oral
- Inhalation
- Carrier
- Injection
- Targeted
- Others
By Product Type
- Nanocarriers
- Micro Needle Patch
- Hydrogel
- Drug Eluting Lens
By End User
- Hospitals
- Specialized clinics
- Others
By Geography
- North America
o U.S.
o Canada
o Mexico
- Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
- Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
- Latin America
o Brazil
o Argentina
o Colombia
- MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
For more information about this report visit:-
https://analyticsmarketresearch.com/reports/advanced-drug-delivery-systems-market/122/
Frequently Asked Questions About This Report
- How big is the Market?
- What is the Market growth?
- Which segment accounted for the largest Market share?
- Who are the key companies/players in the Market?
- What are the factors driving the Market?
- How has the Covid-19 pandemic affected the Market?
- What is the leading solution segment in the Market?
- What is the leading deployment segment in the Market?
- Which enterprise segment accounted for the largest revenue share in the Market?
